Non-obese NAFLD had no better cardio-metabolic risk profile than obese NAFLD in type 2 diabetic patients

被引:8
|
作者
Zhang, Ziyin [1 ,2 ]
Zhang, Lu [1 ,2 ]
Jiang, Wangyan [1 ,2 ]
Du, Tingting [1 ,2 ]
Yuan, Gang [1 ,2 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Endocrinol, Wuhan 430030, Peoples R China
[2] Branch Natl Clin Res Ctr Metab Dis, Wuhan, Peoples R China
关键词
Non-obese non-alcoholic fatty liver disease; Cardio-metabolic risk; Type 2 diabetes mellitus; FATTY LIVER-DISEASE; PREVALENCE; ASSOCIATION;
D O I
10.1186/s12933-022-01648-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Non-obese non-alcoholic fatty liver disease (NAFLD) has been reported to share clinical outcomes with its obese counterpart in the general population. However, conflicting results have been observed regarding the cardio-metabolic risk profile of non-obese NAFLD as compared to obese NAFLD. Moreover, in the context of type 2 diabetes mellitus (T2DM), this issue has been even less addressed. We hence aimed to examine the association of NAFLD with the cardio-metabolic risk profile in patients with T2DM according to their obesity status. Methods A total of 2,708 patients with T2DM who were hospitalized between June 2018 and May 2021 were cross-sectionally assessed. Results The prevalence of NAFLD was 49.3%. NAFLD was found in 34.1% of non-obese patients and 66.0% of obese patients. Non-obese NAFLD patients had more and worse metabolic disorders than obese patients without NAFLD in both men and women. Comparable cardio-metabolic risk profiles were noted between non-obese and obese NAFLD subjects. The associations of worse cardio-metabolic risk profiles with NAFLD were overall stronger in non-obese than in obese subjects among women with T2DM, while more pronounced in obese than in non-obese subjects among men with T2DM. Conclusion In patients with T2DM, non-obese NAFLD had no better cardio-metabolic risk profile than obese NAFLD. The associations of metabolic disorders with NAFLD were stronger in non-obese than in obese patients in women patients with T2DM.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Prevalence and Risk Factors of Non-Alcoholic Fatty Liver Disease (NAFLD) in Non-Obese Patients with Schizophrenia: A Retrospective Study
    Yi, Wenying
    Wu, Haibo
    Fu, Weibin
    Feng, Huimei
    Huang, Jie
    Li, Haijing
    Song, Zhen
    Chen, Yuwei
    Zheng, Yingjun
    She, Shenglin
    DIABETES METABOLIC SYNDROME AND OBESITY, 2024, 17 : 841 - 849
  • [32] Serum leptin levels reduced in non-obese type 2 diabetic patients
    Mohammadzadeh, Ghorban
    Zarghami, Nosratollah
    CLINICAL BIOCHEMISTRY, 2011, 44 (13) : S131 - S131
  • [33] METABOLIC SURGERY FOR NON-OBESE TYPE 2 DIABETES MELLITUS ASIAN PATIENTS
    Lee, Wei-Jei
    Ser, Kong-Han
    Lee, Ming-Hsien
    Chen, Shu-Chu
    Tsou, Jun-Juin
    Chen, Jung-Chien
    OBESITY SURGERY, 2015, 25 (08) : 1310 - 1310
  • [34] Hormonal-metabolic patterns of dyslipidaemias in non-obese type II diabetic patients with atherosclerosis
    Anestiadis, B.
    Anestiadi, V.
    Anestiadi, Z.
    Tsiple, I.
    Cosciug, I.
    ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 177 - 177
  • [35] HORMONAL-METABOLIC PATTERNS OF DYSLIPIDAEMIAS IN NON-OBESE TYPE II DIABETIC PATIENTS WITH ATHEROSCLEROSIS
    Anestiadi, V. V.
    Anestiadi, V.
    Anestiadi, Z.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 71 - 71
  • [36] HORMONAL-METABOLIC ASPECTS OF HYPERLIPIDAEMIAS IN NON-OBESE TYPE II DIABETIC PATIENTS WITH ATHEROSCLEROSIS
    Anestiadi, V.
    Anestiadis, V.
    Anestiadi, Z.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 127 - 127
  • [37] Therapeutic Effect of Metformin on Chemerin in Non-Obese Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)
    Zhuang Xianghua
    Sun Fudun
    Li Liang
    Jiang Dongqing
    Li Xiaobo
    Sun Aili
    Pan Zhe
    Lou Nengjun
    Zhang Liang
    Lou Fuchen
    CLINICAL LABORATORY, 2015, 61 (10) : 1409 - 1414
  • [38] LIPID PEROXIDATION AND THE RESPONSE OF THE ANTIOXIDANT DEFENSE SYSTEM IN THE OBESE TYPE 2 DIABETIC COMPARED WITH THE NON-OBESE TYPE 2 DIABETIC
    Gaxioa-Robles, Ramon
    Kurt Bitzer-Quintero, Oscar
    Celina Mendez-Rodriguez, Lia
    Labrada-Martagon, Vanessa
    Garcia-Gonzalez, Adolfo
    Javier Ramirez-Jirano, Luis
    Velez-Alavez, Marcela
    Zenteno-Savin, Tania
    NUTRICION HOSPITALARIA, 2013, 28 (06) : 1905 - 1911
  • [39] Leptin concentration in obese and non-obese type2 male diabetic subjects.
    Ali, S
    Irfan, K
    Mehmood, S
    Singh, SP
    JOURNAL OF INVESTIGATIVE MEDICINE, 2000, 48 (05) : 264A - 264A
  • [40] miR-29 regulates metabolism by inhibiting JNK-1 expression in non-obese patients with type 2 diabetes mellitus and NAFLD
    Lu, Fangdong
    Gong, Huaping
    Duan, Linhai
    Yan, Yuan
    Chen, Long
    Peng, Pei
    Zhang, Qiaoan
    Song, Wenrong
    Li, Jia
    OPEN MEDICINE, 2023, 18 (01):